Exclusive special offer and discount title banner vector image

GLOBAL MAREK’S DISEASE VACCINE MARKET FORECAST 2023-2032

SCOPE OF THE REPORT


MARKET OVERVIEW

The global Marek’s disease vaccine market is expected to reach $302.08 million by 2032, growing at a CAGR of 7.83% during the forecast period 2023-2032. The base year considered for the study is 2022, and the estimated period is between 2023 and 2032. The market study has also analyzed the impact of COVID-19 on the global Marek’s disease vaccine market qualitatively as well as quantitatively. 

Marek’s disease vaccine is a crucial component of poultry health management, primarily designed to protect chickens from Marek’s disease virus (MDV) infection. These vaccines are available in various types, including live attenuated and inactivated versions; however, live vaccines are the most commonly used. When administered to young birds, often within the first few days after hatching, these vaccines stimulate the bird’s immune system to produce antibodies and develop immunity against MDV. This immunity becomes vital if the bird is exposed to the virulent form of the virus, as it prevents the development of clinical disease. 

Proper vaccination is highly effective in reducing the severity of Marek’s disease and the risk of death in infected birds. In commercial poultry farming, vaccination is a central part of biosecurity measures to ensure flock health and productivity. Veterinarians also play a crucial role in determining the appropriate vaccination strategy, including vaccine selection, administration methods, and ongoing monitoring for vaccine efficacy.

Marek’s Disease Vaccine Market

Read our latest blog on the Poultry Disease Vaccine Market

GROWTH ENABLERS

Key growth enablers of the global Marek’s disease vaccine market growth: 

  • Growing demand for poultry products
    • Consumption of poultry products, including meat and eggs, has increased globally due to factors such as population growth, urbanization and rising incomes, with chicken being the dominant choice due to its affordability and nutritional profile.
    • Poultry meat and egg production has grown significantly over the years, with global poultry meat production reaching 133 million tons and egg production totaling 93 million tons in 2020. Regions like Brazil, the United States, the European Union, and Thailand have become major poultry exporters to meet the rising demand.
    • Marek’s disease, a viral infection in chickens, poses economic risks to poultry farmers. With increased poultry production, the demand for Marek’s disease vaccines is expected to rise as farmers seek to protect their flocks and prevent productivity losses associated with the disease. Thus, the surging worldwide demand for poultry products has a direct impact on the Marek’s disease vaccine market.
  • Government initiatives to control Marek’s disease
  • Rising use of Marek’s disease vaccine technology in various industries

GROWTH RESTRAINTS

Key growth restraining factors of the global Marek’s disease vaccine market:

  • Competition from alternative disease control measures
  • Lack of awareness and education
    • The Marek’s disease vaccine market is facing challenges due to limited awareness and education about the condition and the benefits of vaccination among poultry farmers. Understanding proper vaccination techniques and schedules is another hurdle; improper administration of the vaccine can reduce its effectiveness and increase susceptibility to Marek’s disease.
    • To address these challenges, active promotion of awareness and education is essential. Providing farmers with information about the risks of Marek’s disease and the efficacy of vaccines can empower them to take proactive measures for disease prevention.
    • Educating poultry farmers about Marek’s disease and vaccination benefits can also enable them to make informed decisions about protecting their flocks, potentially contributing to the growth of Marek’s disease vaccine market. 
  • Challenges in handling, transporting, and storing vaccines

To Know More About This Report, Request a Free Sample Copy

DISEASE OVERVIEW

Global Marek’s Disease Vaccine Market | Disease Overview

  • Introduction
  • Symptoms
    • Marek’s disease symptoms include vision impairment, skin changes around feather follicles, tumors in various organs, lameness, limb paralysis, weight loss, difficulty in breathing, diarrhea, and, in some cases, blindness with cataracts or pupil dilation. There are two primary types of symptoms: the nervous form (paralysis of limbs and neck) and the visceral form (tumors in internal organs).
  • Causes
  • Diagnosis
    • Diagnosing Marek’s disease involves standard criteria like assessing clinical signs, gross pathology, and histopathology. Advanced methods include immunohistochemistry, PCR, virus isolation, and serology. Enlarged nerves and lymphoid tumors are common diagnostic indicators. Differential diagnosis is important due to similar-looking tumors and non-tumor diseases.
  • Treatment

GEOGRAPHICAL STUDY

Geographical Study based on Four Major Regions:

  • North America: The United States and Canada
    • North America is anticipated to be the largest regional market, with a share of 31.26% in 2022. The growing poultry industries in both the United States and Canada contribute to the expansion of the North America Marek’s disease vaccine market. 
    • Furthermore, the industry’s emphasis on disease prevention, substantial poultry populations, and increasing demand for poultry products drive the need for effective vaccination strategies, creating a favorable landscape for the studied market. 
    • The region has a strong presence of Marek’s disease vaccine manufacturers such as Merck Animal Health, Zoetis Inc and Ceva Santé Animale. 
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Belgium, Poland and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Vietnam, Indonesia, Thailand, Australia & New Zealand, and Rest of Asia-Pacific
  • Rest of World: Latin America, the Middle East & Africa

MAJOR PLAYERS

Major players in the global Marek’s disease vaccine market:

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Hester Biosciences Limited
  • Merck Animal Health
  • Venky’s India 
  • Zoetis

REPORT SYNOPSIS

REPORT SCOPEDETAILS
Market Forecast Years2023-2032
Base Year2022
Market Historical Years2018-2022
Forecast UnitsRevenue ($ Million)
Geographies AnalyzedNorth America, Europe, Asia-Pacific, and Rest of World
Companies AnalyzedBoehringer Ingelheim International GmbH, Ceva Sante Animale, Hester Biosciences Limited, Merck Animal Health, Venky’s India, Zoetis
 

TABLE OF CONTENT

  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. DISEASE OVERVIEW
    1. INTRODUCTION
    2. SYMPTOMS
    3. CAUSES
    4. DIAGNOSIS
    5. TREATMENT
  4. MARKET DYNAMICS
    1. KEY DRIVERS
      1. GROWING DEMAND FOR POULTRY PRODUCTS
      2. GOVERNMENT INITIATIVES TO CONTROL MAREK’S DISEASE
      3. RISING USE OF MAREK’S DISEASE VACCINE TECHNOLOGY IN VARIOUS INDUSTRIES
    2. KEY RESTRAINTS
      1. COMPETITION FROM ALTERNATIVE DISEASE CONTROL MEASURES
      2. LACK OF AWARENESS AND EDUCATION
      3. CHALLENGES IN HANDLING, TRANSPORTING, AND STORING VACCINES
  5. MARKEK’S DISEASE PIPELINE ANALYSIS
    1. ANALYSIS BY CANDIDATE
    2. ANALYSIS BY DEVELOPMENT APPROACH
    3. ANALYSIS BY PHASE
    4. DRUG PROFILING
    5. CLASSIFICATION OF MD VACCINES
  6. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. UNITED STATES
        2. CANADA
    2. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. UNITED KINGDOM
        2. GERMANY
        3. FRANCE
        4. ITALY
        5. SPAIN
        6. BELGIUM
        7. POLAND
        8. REST OF EUROPE
    3. ASIA-PACIFIC
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. CHINA
        2. JAPAN
        3. INDIA
        4. SOUTH KOREA
        5. INDONESIA
        6. THAILAND
        7. VIETNAM
        8. AUSTRALIA & NEW ZEALAND
        9. REST OF ASIA-PACIFIC
    4. REST OF WORLD
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. REGIONAL ANALYSIS
        1. LATIN AMERICA
        2. MIDDLE EAST & AFRICA
  7. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. PRODUCT LAUNCHES & DEVELOPMENTS
    2. COMPANY PROFILES
      1. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      2. CEVA SANTE ANIMALE
      3. HESTER BIOSCIENCES LIMITED
      4. MERCK ANIMAL HEALTH
      5. VENKY’S INDIA
      6. ZOETIS

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – GLOBAL MAREK’S DISEASE VACCINE MARKET

TABLE 2: GLOBAL MAREK’S DISEASE VACCINE MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 3: GLOBAL MAREK’S DISEASE VACCINE MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 4: NORTH AMERICA MAREK’S DISEASE VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 5: NORTH AMERICA MAREK’S DISEASE VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 6: EUROPE MAREK’S DISEASE VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 7: EUROPE MAREK’S DISEASE VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 8: ASIA-PACIFIC MAREK’S DISEASE VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 9: ASIA-PACIFIC MAREK’S DISEASE VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 10: REST OF WORLD MAREK’S DISEASE VACCINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)

TABLE 11: REST OF WORLD MAREK’S DISEASE VACCINE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)

TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

LIST OF FIGURES

FIGURE 1: NORTH AMERICA MAREK’S DISEASE VACCINE MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 2: UNITED STATES MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 3: CANADA MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 4: EUROPE MAREK’S DISEASE VACCINE MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 5: UNITED KINGDOM MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 6: GERMANY MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 7: FRANCE MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 8: ITALY MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 9: SPAIN MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 10: BELGIUM MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 11: POLAND MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 12: REST OF EUROPE MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 13: ASIA-PACIFIC MAREK’S DISEASE VACCINE MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)

FIGURE 14: CHINA MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 15: JAPAN MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 16: INDIA MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 17: SOUTH KOREA MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 18: INDONESIA MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 19: THAILAND MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 20: VIETNAM MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 21: AUSTRALIA & NEW ZEALAND MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 22: REST OF ASIA-PACIFIC MAREK’S DISEASE VACCINE MARKET, 2023-2032 (IN $ MILLION)

FIGURE 23: REST OF WORLD MAREK’S DISEASE VACCINE MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)

FAQ’s

FAQs

As of 2022, the global Marek’s disease vaccine market was valued at $141.93 million.

No, there is no specific treatment for Marek’s disease. Infected birds usually receive supportive care, which may involve antibiotics to prevent secondary infections and pain medication for comfort.